OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Darolutamide
16 minutes
Posted Jul 31, 2019 at 7:37 pm.
0:00
16:44
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Darolutamide has been FDA-approved. We discuss its differences and similarities to other 2nd-generation anti-androgens (enzalutamide & apalutamide) - especially potential drug interactions!
Previous
AC - - > T (q week)
Next
ASCO VTE Guidelines (& more!)
← See all 273 episodes of OncoPharm